TIAA CREF Investment Management’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History
Bought
Maintained
Sold
Other funds holding OSIR
HP
FIM
FPF
IA
MAM
TIAA CREF Investment Management's OSIR Position: Q1 2017 in Review
TIAA CREF Investment Management sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2017, closing a stake of 52,276 shares — an estimated $257K sold.
TIAA CREF Investment Management first reported a position in OSIR in Q2 2013 and held it in 15 quarters. The position peaked at $1.2M in Q4 2013. 11 funds tracked by Wall St. Rank hold OSIR as of Q1 2017.
- TIAA CREF Investment Management reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
- TIAA CREF Investment Management sold 52,276 Osiris Therapeutics, Inc. Common Stock shares in Q1 2017, an estimated $257K.
- TIAA CREF Investment Management first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 15 quarters.
- TIAA CREF Investment Management's Osiris Therapeutics, Inc. Common Stock position peaked at $1.2M in Q4 2013.
- 11 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2017.
Based on TIAA CREF Investment Management's 13F filing for Q1 2017, filed 11 May 2017.